サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1729415

日本の医薬品3PL市場レポート：サービス、温度管理、地域別、2025年～2033年

Japan Pharmaceutical 3PL Market Report by Service, Temperature Control, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 121 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.37円
日本の医薬品3PL市場レポート：サービス、温度管理、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 121 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の医薬品3PLの市場規模は2024年に59億米ドルに達しました。IMARC Groupは、2025年から2033年にかけての成長率（CAGR）は10.26%で、2033年には152億米ドルに達すると予測しています。製薬企業が、流通やコンプライアンスといった複雑な要求に煩わされることなく、医薬品開発や研究といったコアコンピタンスに注力する傾向が強まっていることが、主に市場成長の原動力となっています。

本レポートで扱う主な質問

  • 日本の医薬品3PL市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本の医薬品3PL市場に与えた影響は？
  • 日本の医薬品3PL市場のサービス別区分は？
  • 日本の医薬品3PL市場の温度管理別の区分は？
  • 日本の医薬品3PL市場のバリューチェーンにおける様々なステージとは？
  • 日本の医薬品3PLの主な促進要因と課題は何か？
  • 日本の医薬品3PL市場の構造と主要プレーヤーは？
  • 日本の医薬品3PL市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の医薬品3PL市場：イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の医薬品3PL市場情勢

  • 過去および現在の市場動向（2019～2024年）
  • 市場予測（2025～2033年）

第6章 日本の医薬品3PL市場：サービス別の内訳

  • 国内輸送管理
  • 国際輸送管理
  • 付加価値倉庫・配送

第7章 日本の医薬品3PL市場：温度制御別の内訳

  • 管理/コールドチェーン物流
  • 非管理/非コールドチェーン物流

第8章 日本の医薬品3PL市場：競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第9章 主要企業のプロファイル

第10章 日本の医薬品3PL市場：業界分析

  • 促進要因、抑制要因、機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第11章 付録

目次
Product Code: SR112025A17286

Japan pharmaceutical 3PL market size reached USD 5.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.2 Billion by 2033, exhibiting a growth rate (CAGR) of 10.26% during 2025-2033. The increasing focus of pharmaceutical companies on their core competencies, like drug development and research, without being encumbered by the intricate demands of distribution and compliance, is primarily driving the market growth.

Third-party logistics (3PL) in the pharmaceuticals sector plays a pivotal role in optimizing the supply chain for drug manufacturers and distributors. Pharmaceutical 3PL providers offer specialized logistics services, ensuring that medications are stored, handled, and transported under stringent regulatory standards, guaranteeing their efficacy and safety. Given the critical nature of pharmaceuticals and their direct impact on patient health, there's an inherent need for precision, timeliness, and compliance within this logistical framework. Today, as the pharmaceutical industry grapples with a globalized market, rising demand, and complex regulatory environments, these 3PL providers become instrumental in navigating these challenges. By integrating advanced technologies, real-time tracking, and compliance management, pharmaceutical 3PLs offer a seamless bridge between manufacturers and end-users, ensuring that lifesaving medications reach their destinations promptly and in optimal condition.

Japan Pharmaceutical 3PL Market Trends:

The Japan pharmaceutical 3PL market is characterized by the nation's healthcare supply chain, epitomizing efficiency, precision, and compliance. One of the primary drivers is the complex regulatory environment surrounding pharmaceuticals. With stringent guidelines on storage, transportation, and distribution, many pharma companies are opting to outsource these logistics challenges to 3PL providers equipped with specialized knowledge and infrastructure. Technological integration is another trend shaping the market. The rise of IoT devices, AI-driven analytics, and blockchain ensures real-time monitoring, enhanced security, and transparent traceability throughout the drug supply chain. This not only improves efficiency but also minimizes the risk of counterfeits or compliance breaches. Furthermore, with Japan's geographical intricacies and the need for last-mile delivery solutions, especially to its aging rural population, 3PL providers are innovating to ensure that medications reach even the most remote areas. Lastly, the ongoing global health challenges have underscored the importance of a robust and agile supply chain. The pandemic-induced disruptions have made pharmaceutical companies more reliant on 3PL partners to navigate uncertainties and ensure continuity of supply. In essence, the combination of regulatory demands, technological advancements, demographic challenges, and health scenarios are projected to propel the Japan pharmaceutical 3PL market for significant growth over the forecasted period.

Japan Pharmaceutical 3PL Market Segmentation:

Service Insights:

  • Domestic Transportation Management
  • International Transportation Management
  • Value-added Warehousing and Distribution

Temperature Control Insights:

  • Controlled/Cold Chain Logistics
  • Non-controlled/Non-Cold Chain Logistics

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

  • DHL
  • FedEx Corporation
  • Kerry Logistics Network Limited (SF Express Co. Ltd.)
  • Kuehne + Nagel
  • Nippon Express Co. Ltd.
  • Suzuken Co. Ltd.

Key Questions Answered in This Report:

  • How has the Japan pharmaceutical 3PL market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan pharmaceutical 3PL market?
  • What is the breakup of the Japan pharmaceutical 3PL market on the basis of service?
  • What is the breakup of the Japan pharmaceutical 3PL market on the basis of temperature control?
  • What are the various stages in the value chain of the Japan pharmaceutical 3PL market?
  • What are the key driving factors and challenges in the Japan pharmaceutical 3PL?
  • What is the structure of the Japan pharmaceutical 3PL market and who are the key players?
  • What is the degree of competition in the Japan pharmaceutical 3PL market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmaceutical 3PL Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Pharmaceutical 3PL Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Pharmaceutical 3PL Market - Breakup by Service

  • 6.1 Domestic Transportation Management
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 International Transportation Management
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Value-added Warehousing and Distribution
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)

7 Japan Pharmaceutical 3PL Market - Breakup by Temperature Control

  • 7.1 Controlled/Cold Chain Logistics
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Non-controlled/Non-Cold Chain Logistics
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan Pharmaceutical 3PL Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 DHL
    • 9.1.1 Business Overview
    • 9.1.2 Services Offered
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 FedEx Corporation
    • 9.2.1 Business Overview
    • 9.2.2 Services Offered
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Kerry Logistics Network Limited (SF Express Co. Ltd.)
    • 9.3.1 Business Overview
    • 9.3.2 Services Offered
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Kuehne + Nagel
    • 9.4.1 Business Overview
    • 9.4.2 Services Offered
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Nippon Express Co. Ltd.
    • 9.5.1 Business Overview
    • 9.5.2 Services Offered
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events
  • 9.6 Suzuken Co. Ltd.
    • 9.6.1 Business Overview
    • 9.6.2 Services Offered
    • 9.6.3 Business Strategies
    • 9.6.4 SWOT Analysis
    • 9.6.5 Major News and Events

10 Japan Pharmaceutical 3PL Market - Industry Analysis

  • 10.1 Drivers, Restraints and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

11 Appendix